Analyst Report: LRCX
1. EXECUTIVE SUMMARY
Lam Research fell 12.75% over the week to a $237.50 close on Monday 26 October 2026, and almost all of the damage came in one session. On 22 October, the first full session after the September-quarter report, the shares dropped 11.76% to $230.15 on volume of 22,998,200. The company reported record revenue of $8.22bn and non-GAAP EPS of $2.20 (Lam press release, 21 October). The sell-off followed CFO Doug Bettinger's remark that the December-quarter revenue guide of about $8.6bn "would have been a bit higher if not for some near-term supply chain constraints" (Yahoo Finance, 22 October). The semiconductor group fell with it, and LRCX lost more than each of the four peers over the week. Management says the held-back sales should ship in the March quarter (Trefis, 26 October). The shares closed Monday 3.22% above the post-earnings low, and the brief identifies no catalyst for that bounce.
2. THE CATALYST
Lam reported fiscal Q1 2027 after the close on 21 October. The figures from the company's press release and 8-K:
| Item | Result |
|---|---|
| Revenue | $8.22bn, up 22% sequentially |
| Non-GAAP diluted EPS | $2.20 |
| GAAP operating margin | 40.0%, from 37.4% |
| December-quarter revenue guide | $8.6bn, plus or minus $400m |
| Quarterly dividend | $0.33, from $0.26 |
The guide drew the selling. Yahoo Finance reported that the shares fell as much as 11% intraday on 22 October after Bettinger's comment about supply constraints. CEO Tim Archer described a longer runway for the bottleneck, with clean-room space and certain component supplies limiting chipmakers and equipment makers into calendar 2027 (24/7 Wall St, 22 October). Trefis reported that Lam expects sales held back by supply limits to ship in the March quarter and that China's share of revenue will fall in the December quarter.
Options had priced a move of about 6.2% either way after the report (TipRanks via CNN, 21 October). The 11.76% close-to-close drop on 22 October came to roughly twice that.
| Session | Close | Change | Volume |
|---|---|---|---|
| 21 Oct (report after close) | $260.81 | -1.00% | 16,027,300 |
| 22 Oct | $230.15 | -11.76% | 22,998,200 |
| 23 Oct | $230.10 | -0.02% | 12,731,400 |
| 26 Oct | $237.50 | +3.22% | 11,638,300 |
3. COMPANY PROFILE
Lam Research (market cap $297.21bn) makes semiconductor processing equipment used in chip fabrication. Its products include ALTUS deposition systems for tungsten and molybdenum metallization, SABRE electrochemical deposition tools for copper interconnect, and Striker single-wafer atomic layer deposition products. It sells into the United States, China, Korea, Taiwan, Japan, Southeast Asia and Europe. Its peers in semiconductor materials and equipment include Applied Materials, KLA, Teradyne and Qnity.
Trefis calls the September quarter the fifth straight quarter of record revenue and notes that the twelve-month operating margin is the highest in data back to fiscal 2017. Management credited the record gross margin to a favourable customer and product mix. Lam bought back about $1.02bn of stock in the quarter (Stocktitan, 21 October) and raised the quarterly dividend to $0.33 from $0.26. Management expects chipmaker wafer-fab equipment spending to top $200bn in 2027, up from the mid-$150bn range expected for 2026 (Trefis).
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The quarter itself gave no cause for a sell-off: revenue grew 22% sequentially and margins widened. The guide of $8.6bn sits in the middle of the $8.2bn to $9.0bn range that Trefis cites, and the cause of the selling was the statement that it could have been higher. In my inference, the market read this as confirmation that supply, rather than demand, limits Lam's growth for several quarters, and the shares had already weakened before the print. The stock closed at $301.11 on 13 October and $260.81 on 21 October, so the shares entered the report down about 13%. The stock is down 24.48% over 20 sessions and 18.86% over 60 sessions, and sits well below the 52-week high of $438.03 set on 30 June.
Sector read-across. The PHLX Semiconductor Index fell 6.72% on 22 October with all 30 constituents lower (Arabian Post), and one estimate put the lost sector value near $200bn (TechTimes, 23 October). Arm fell 7.28% that day, with the drop attributed to Lam's warning, and Marvell and AMD each fell about 8% in the morning session (24/7 Wall St). Motley Fool called it the sector's worst day since June. Over the week to 26 October, peers moved as follows, against -0.18% for the S&P 500:
| Stock | Change |
|---|---|
| LRCX | -12.75% |
| KLAC | -10.33% |
| TER | -7.91% |
| AMAT | -6.18% |
| Q | -4.18% |
Analyst reaction. Most cuts to price targets landed on 22 October, and every rating in the brief stayed at Buy, Outperform or Overweight.
| Firm | Rating | Target change |
|---|---|---|
| Citigroup | Buy | $450 to $435 |
| Mizuho | Outperform | $365 to $360 |
| Morgan Stanley | Overweight | $385 to $339 |
| Needham | Buy | $390 to $290 |
| UBS | Buy | $425 to $400 |
| DBS (23 Oct) | Buy | $416 set, prior target unavailable |
Evercore ISI cut its target from $355 to $315 on 20 October, before the report. Consensus figures from the sources conflict: Ticker Nerd shows a median of $353, MarketBeat an average of $354.55, and TipRanks an average of $401.68. The brief cannot reconcile them.
Comparable episodes. After the 29 July report the shares rose 16.1% over two trading days (Trefis), so October is the first sharp post-earnings sell-off in the sources. In the 2022 inflation shock the stock fell 56% while the S&P 500 fell 24%.
Bull case. Revenue is record, margins are widening, and delayed sales are expected to ship in the March quarter. Management sees wafer-fab equipment spending above $200bn in 2027. The forward P/E is 19.5 against a trailing 35.4, which indicates the market expects earnings to grow substantially. Archer argued the tightness differs from the COVID-era shortages and that the industry should catch up soon, which is a management view and not an independent forecast.
Bear case. Supply limits through 2027 cap how fast Lam can convert demand into revenue. China's share of sales is falling, and the data-centre spending behind the chip rally has drawn scrutiny. The broad decline across chip stocks shows that holders treat the sector as one trade, which keeps Lam exposed to further sector selling regardless of its own results.
5. TECHNICAL SNAPSHOT
At $237.50 the shares sit below both the 50-day average of $300.33 and the 200-day average of $283.20, and well under the 52-week high of $438.03 while staying far above the 52-week low of $134.88. The nearest support is $230.10, the 23 October close, which sits just below the $230.15 close from 22 October, the day of the drop. The nearest resistance is $260.81, the 21 October close, which marks the level before the report. Volume on 22 October was 22,998,200, more than double the 50-session average of 9,080,504, which marks heavy repositioning. The 26 October bounce came on 11,638,300 shares, 1.28 times the average, so the rebound drew only modest participation.
6. RISK FACTORS
- Supply constraints persist. Archer pointed to clean-room space and component limits into calendar 2027, and the March-quarter catch-up depends on those easing.
- Sector contagion. Selling in AI-linked names pulled the whole index lower on 22 October. A further move against data-centre spending would hit Lam again whatever its own results show.
- China mix. Management expects China's share of revenue to fall in the December quarter.
- Estimate resets. Analysts cut targets sharply, and the consensus sources disagree widely.
- Unconfirmed items. The brief carries unverified reports of Citi warning on AI-spending worries and of Sandisk flagging memory supply limits on 25 October. Neither can be relied on.
Dated catalysts:
- 4 November 2026: Arm reports fiscal Q2. Its guidance and supply commentary on its AGI CPU ramp bear directly on the supply-chain thesis (TIKR).
- January 2027: Lam's December-quarter report, expected per Trefis. Revenue against the $8.2bn to $9.0bn guidance range is the figure to watch.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). The shares hold above the $230.10 close, and the bounce on 26 October lacks a sourced catalyst. A close below $230.10 would put the post-earnings low at risk, while a recovery toward $260.81 would need fresh buying across the sector. Arm's 4 November report is the next external test of the supply theme.
Medium term (1-3 months). Direction depends on evidence that supply limits ease and that the shipments pushed out of the December quarter arrive in March. Reports from other equipment and chip makers on component availability will carry weight, and the January report will show whether revenue lands above the $8.6bn midpoint. A result at the low end of the $8.2bn to $9.0bn range would reinforce the bear case.
Long-term thesis. The brief contains nothing that changes the thesis: record revenue, rising margins, a higher dividend, continued buybacks and a wafer-fab equipment spending outlook above $200bn in 2027. The sell-off altered the timing of revenue and left the demand case intact, though the pace of growth now rests on suppliers and clean-room construction outside Lam's control. This is analysis, not personal financial advice.